arrow
E

Eduardo Magalhães Rego

Instituto d'or de Pesquisa e Ensino
H指数:44
被引数:8,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health-related quality of life with mosunetuzumab plus polatuzumab vedotin in R/R LBCL: Phase 3 SUNMO trial

mosunetuzumab联合polatuzumab vedotin在R/R LBCL中的健康相关生活质量:III期SUNMO试验

2026-10-120
OAAI
SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models

SLIT2调节急性髓系白血病模型中白血病细胞的增殖和基质支持

2026-09-290
PRE
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape

Quizartinib诱导的耐药性驱动具有分子改变以实现多药抗白血病逃逸的MV4-11细胞的克隆出现

2026-04-150
OAAI
Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia

代谢重编程代表了克服急性髓系白血病中维奈克拉获得性耐药的可靶向机制。

2025-10-010
PRE
Challenges in Evaluating Thromboembolic Risk in Acute Leukemia: Clinical Profiling and Limitations of Current Scoring Systems

急性白血病中血栓栓塞风险评估的挑战:临床特征及当前评分系统的局限性

2025-08-190
OAAI
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability

高mtDNA含量可识别氧化磷酸化驱动的急性髓性白血病,并代表治疗脆弱性

2025-07-140
OAAI
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells

ezrin的药理抑制作用可降低急性淋巴细胞白血病细胞的增殖和侵袭表型

2025-01-010
PRE
The Oncogenic ΔNp73α Isoform Contributes to Aggressiveness in APL By Leading to ATRA Resistance through NANOG/BMP4 Axis Upregulation

癌基因ΔNp73α异构体通过上调NANOG/BMP4轴导致ATRA耐药性,从而促进APL的侵袭性。

BLOOD
IF23.1
2024-11-050
PRE
Impact of Ph-like Gene Signatures on Clinical Outcomes in Adult B-ALL Patients in Resource-Constrained Settings

Ph-like基因特征对资源受限环境中成人B-ALL患者临床结局的影响

BLOOD
IF23.1
2024-11-050
PRE
The Oncogenic Function of the Intrinsically Disordered Transcriptional Regulator MN1 Depends on the Chaperone DNAJB6b

内源无序转录调控因子MN1的致癌功能依赖于分子伴侣DNAJB6b

BLOOD
IF23.1
2024-11-050
PRE
High Leukemic Stem Cell Frequency in FLT3-Mutated Acute Myeloid Leukemia Patients with Normal Karyotype: Implications for Prognosis

正常核型 FLT3-突变急性髓系白血病患者中高白血病干细胞频率:对预后的影响

BLOOD
IF23.1
2024-11-050
PRE
The Impact of Clinical Features on Survival and Relapse of Patients Diagnosed With T-cell Acute Lymphoblastic Leukemia - a Multicenter Cohort Study

T细胞急性淋巴细胞白血病患者临床特征对其生存和复发的影响——一项多中心队列研究

2024-11-010
PRE
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid

急性早幼粒细胞白血病的早期死亡和颅内出血预测: 在接受化疗加全反式维甲酸治疗的国际联盟队列中验证风险评分

2024-10-310
OAAI
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia

药理学PIP4K2抑制剂在急性淋巴细胞白血病中的效力和疗效

2024-08-011
PRE
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia
2024-06-240
OAAI